Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the U.S. organizations selected as part of Teva’s 2016 Community Partnership Program. Now in its fifth year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that suppo...
Teva Pharmaceuticals is now accepting entries for the 2016 Teva Community Partnership Program. Now in its fifth year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that support patients and their caregivers in geo...
/PRNewswire/ - Teva Pharmaceuticals, in collaboration with the Philadelphia Eagles, today announced that it has awarded four grants totaling $125,000 to Philabundance, Students Run Philly Style, Twilight Wish Foundation and The Miracle League of Northampton Township, as part...